MYXOID LIPOSARCOMA
Clinical trials for MYXOID LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new MYXOID LIPOSARCOMA trials appear
Sign up with your email to follow new studies for MYXOID LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental immune therapy targets Tough-to-Treat sarcomas
Disease control OngoingThis study is testing whether a personalized immune cell therapy can help control advanced synovial sarcoma or myxoid liposarcoma. Doctors take a patient's own immune cells, genetically modify them to recognize cancer, and infuse them back. The trial will measure how well tumors …
Matched conditions: MYXOID LIPOSARCOMA
Phase: PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
First human test of novel cancer vaccine begins
Disease control OngoingThis is an early safety study testing a new cancer vaccine called PeptiCRAd-1, given alongside the immunotherapy drug pembrolizumab. It aims to see if this combination is safe and can activate the immune system to fight cancer in patients with advanced solid tumors that have stop…
Matched conditions: MYXOID LIPOSARCOMA
Phase: PHASE1 • Sponsor: Valo Therapeutics Oy • Aim: Disease control
Last updated Mar 03, 2026 14:07 UTC